Literature DB >> 32372311

Impact of Extracapsular Extension of Lymph Node in Adenocarcinoma of the Stomach.

Bofei Li1, Ian Yu-Hong Wong1, Fion Siu-Yin Chan1, Kwan Kit Chan1, Claudia Lai-Yin Wong1, Tsz-Ting Law1, Jeanette Yat-Yin Kwok1, Anthony Wing Ip Lo2, Simon Law3.   

Abstract

BACKGROUND: Extracapsular extension (ECE) of lymph node may have important prognostic impact for patients with adenocarcinoma of the stomach, but it generally is ignored in staging systems and prognostic models. This study aimed to examine the impact that ECE of lymph node has on prognosis for patients with adenocarcinoma of the stomach.
METHODS: The study analyzed 321 consecutive patients with gastric cancer who underwent radical gastrectomy between January 2008 and December 2015. None of these patients had distant metastases. Lymph node metastases were found in 187 patients. The ECE grade was evaluated according to the previously described system used in head and neck cancers. Deposits of cancer cells in sub-serosal fat without a recognizable lymph node were classified as ECE grade 4. Survival outcomes were compared using Kaplan-Meier and Cox regression analyses. A nomogram was constructed using identified significant prognostic factors. The predictive accuracy and model performance were measured by the concordance index (C-index).
RESULTS: Patients with ECE(+) showed significantly worse 3-year overall survival (OS) and disease-free survival (DFS) than those without ECE. In the sensitivity analysis, ECE had independent prognostic value for both 3-year OS and 3-year DFS, whereas ECE grading showed little impact on mortality trend or disease progression trend. The ECE-based nomogram showed a significantly higher C-index than the pathological tumor and node staging (pTN) staging system.
CONCLUSIONS: The adverse prognostic impact of ECE was validated. Sub-serosal tumor deposits without recognizable lymph node tissue are recommended for inclusion in the ECE definition. A nomogram involving ECE could provide better individual prediction of survival for patients with lymph node-positive gastric cancer.

Entities:  

Mesh:

Year:  2020        PMID: 32372311     DOI: 10.1245/s10434-020-08541-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  13 in total

Review 1.  Survival end point reporting in randomized cancer clinical trials: a review of major journals.

Authors:  Simone Mathoulin-Pelissier; Sophie Gourgou-Bourgade; Franck Bonnetain; Andrew Kramar
Journal:  J Clin Oncol       Date:  2008-08-01       Impact factor: 44.544

2.  Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer.

Authors:  Mitsuru Sasako; Shinichi Sakuramoto; Hitoshi Katai; Taira Kinoshita; Hiroshi Furukawa; Toshiharu Yamaguchi; Atsushi Nashimoto; Masashi Fujii; Toshifusa Nakajima; Yasuo Ohashi
Journal:  J Clin Oncol       Date:  2011-10-17       Impact factor: 44.544

3.  Extracapsular extension is a poor predictor of disease recurrence in surgically treated oropharyngeal squamous cell carcinoma.

Authors:  James S Lewis; Danielle H Carpenter; Wade L Thorstad; Qin Zhang; Bruce H Haughey
Journal:  Mod Pathol       Date:  2011-06-24       Impact factor: 7.842

4.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

5.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

6.  Extracapsular lymph node spread: a new prognostic factor in gastric cancer.

Authors:  Hakan Alakus; Arnulf H Hölscher; Guido Grass; Eva Hartmann; Christian Schulte; Uta Drebber; Stephan E Baldus; Elfriede Bollschweiler; Ralf Metzger; Stefan P Mönig
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

7.  Prognostic value of extracapsular invasion and fibrotic focus in single lymph node metastasis of gastric cancer.

Authors:  Takahide Okamoto; Akira Tsuburaya; Yoichi Kameda; Takaki Yoshikawa; Haruhiko Cho; Kazuhito Tsuchida; Shinichi Hasegawa; Yoshikazu Noguchi
Journal:  Gastric Cancer       Date:  2008-09-30       Impact factor: 7.370

8.  Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.

Authors:  Shinichi Sakuramoto; Mitsuru Sasako; Toshiharu Yamaguchi; Taira Kinoshita; Masashi Fujii; Atsushi Nashimoto; Hiroshi Furukawa; Toshifusa Nakajima; Yasuo Ohashi; Hiroshi Imamura; Masayuki Higashino; Yoshitaka Yamamura; Akira Kurita; Kuniyoshi Arai
Journal:  N Engl J Med       Date:  2007-11-01       Impact factor: 91.245

9.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

Review 10.  Review of survival analyses published in cancer journals.

Authors:  D G Altman; B L De Stavola; S B Love; K A Stepniewska
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.